Results 41 to 50 of about 26,508 (157)

Treating myocardial stunning randomly, with either propofol or isoflurane following transient coronary occlusion and reperfusion in pigs

Annals of Cardiac Anaesthesia, 2009
Propofol and isoflurane may be used during fast track anesthesia for off-pump bypass, where transient ischemia is common. The purpose of this study was to compare the effects of propofol vs isoflurane in a porcine model of acute coronary occlusion ...
Urdaneta Felipe, Lobato Emilio, Kirby David, Sidi Avner   +3 more
doaj  

Ablation of ventricular tachycardia in a patient with a left ventricular assist device

Türk Kardiyoloji Derneği Arşivi, 2020
The use of a left ventricular assist device (LVAD) as a bridge to heart transplantation (HTx) or as a destination therapy in patients with a contraindication for HTx is increasing.
Evrim Şimşek, Emin Evren Özcan, Emre Demir, Pelin Öztürk, Sanem Nalbantgil   +4 more
doaj   +1 more source

Is there a difference in bleeding after left ventricular assist device implant: centrifugal versus axial?

Journal of Cardiothoracic Surgery, 2018
Background Continuous-flow left ventricular assist devices (CF-LVAD) have become the standard of care for patients with end stage heart failure. Device reliability has increased, bringing the potential for VAD, compared to transplant, into debate ...
Ann C. Gaffey, Carol W. Chen, Jennifer J. Chung, Jason Han, Christian A. Bermudez, Joyce Wald, Pavan Atluri   +6 more
doaj   +1 more source

A Multidisciplinary Approach to Electrical Instability and Cardiogenic Shock in Acute Myocardial Infarction

JACC: Case Reports, 2020
New cardiogenic shock classifications allow prompt recognition and management of complications of acute coronary syndrome. A 59-year-old man presented after a delayed left anterior descending coronary artery ST-segment elevation myocardial infarction in ...
Shuktika Nandkeolyar, MD, Tahmeed Contractor, MD, Rahul Bhardwaj, MD, Ravi Mandapati, MD, Antoine Sakr, MD, Islam Abudayyeh, MD, Anees Razzouk, MD, Aditya Satish Bharadwaj, MD   +7 more
doaj   +1 more source

Displacement of impella post chest compressions

Heart Views, 2014
The Impella is a left ventricular assist device which is implanted via the transcutaneous femoral route and is placed across the aortic valve into the left ventricle.
Sourabh Aġġarwal, Susan Bannon
doaj   +1 more source

The effect of transfusion of blood products on ventricular assist device support outcomes

ESC Heart Failure, 2020
Aims Perioperative blood transfusions are common among patients undergoing left ventricular assist device (LVAD) implantation. The association between blood product transfusion at the time of LVAD implantation and mortality has not been described ...
Supriya Shore, Thomas C. Hanff, Jeremy A. Mazurek, Matthew Seigerman, Robert Zhang, Edward W. Grandin, Esther Vorovich, Paul Mather, Caroline Olt, Jessica Howard, Joyce Wald, Michael A. Acker, Lee R. Goldberg, Pavan Atluri, Kenneth B. Margulies, J. Eduardo Rame, Edo Y. Birati   +16 more
doaj   +1 more source

Intensive care experiences of patients with implanted left ventricular assist devices: a qualitative study

BMC Cardiovascular Disorders
Background Patients with left ventricular assist device implants experience unique physical, emotional, and psychosocial experiences during their intensive care unit period.
Nihal Celikturk Doruker
doaj   +1 more source

Surgical Outcomes of Centrifugal Continuous-Flow Implantable Left Ventricular Assist Devices: Heartmate 3 versus Heartware Ventricular Assist Device

Journal of Chest Surgery
Background: Left ventricular assist devices (LVADs) are widely employed as a therapeutic option for end-stage heart failure. We evaluated the outcomes associated with centrifugal- flow LVAD implantation, comparing 2 device models: the Heartmate 3 (HM3)
Kinam Shin, Won Chul Cho, Nara Shin, Hong Rae Kim, Min-Seok Kim, Cheol Hyun Chung, Sung-Ho Jung   +6 more
doaj   +1 more source

Left Ventricular Assist Device-Associated Infections: Case Series

Journal of Global Antimicrobial Resistance
AIM: We evaluate the epidemiological, laboratory, and clinical data of left ventricular assist device (LVAD)-associated infections diagnosed based on clinical evaluation, imaging studies, and microbiologic tests.
Bahar Busra Sivrikaya, Ozgur Gunal
doaj   +1 more source

Emergent decommissioning of HeartMate 3 for life-threatening hemorrhage

Journal of Vascular Surgery Cases and Innovative Techniques
Left ventricular assist devices are known for the treatment of heart failure. We present a patient who underwent emergent decommissioning of his left ventricular assist device after experiencing life-threatening hemorrhage.
Reginald E. Du, MD, Ryan S. Bedi, MD, W. Charles Sternbergh, III, MD, Aditya Bansal, MD   +3 more
doaj   +1 more source